Skip to main content
CardioComm Solutions, Inc. logo

CardioComm Solutions, Inc. — Investor Relations & Filings

Ticker · EKG ISIN · CA14159N2086 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 130 across all filing types
Latest filing 2026-01-23 Proxy Solicitation & In…
Country CA Canada
Listing TSXV EKG

About CardioComm Solutions, Inc.

https://cardiocommsolutions.com/

CardioComm Solutions, Inc. is a global provider of advanced medical electrocardiogram (ECG) and multiple bio-sign monitoring solutions. The company develops ISO 13485 certified, FDA cleared, and Health Canada approved software and hardware for both healthcare professionals and consumers. Core offerings include the GEMS™ software platform for ambulatory cardiac long-term continuous monitoring (LTCM) and the Body-by-GEMS (BBG) system, which acts as a central hub for collecting and analyzing bio-signs (including blood pressure, PO2, and temperature) from various devices and wearables. For the consumer market, CardioComm offers personal ECG monitors like the HeartCheck™ CardiBeat, supported by the GEMS™ mobile app and rapid SMART Monitoring ECG reading services, enabling physician review typically within 30 minutes. CardioComm is recognized as a pioneer in personalized ECG monitoring and Remote Patient Monitoring (RPM) technology.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a notice from Computershare to Canadian Securities Regulatory Authorities regarding an upcoming 'Annual General and Special Meeting' for CardioComm Solutions Inc. It outlines key dates such as the record date, meeting date, and proxy-related delivery instructions. This document serves as a formal notification of meeting logistics and proxy-related procedures, which falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides the necessary information for shareholders to prepare for the upcoming meeting.
2026-01-23 English
Other.pdf
Capital/Financing Update Classification · 1% confidence The document is the full text of a financing agreement detailing loan amounts, terms, repayment via royalties, security interests, bonus share and warrant issuance, and related capital structure terms. It is not an earnings release, board change, or regulatory announcement but a comprehensive financing arrangement. This falls squarely under Capital/Financing Update (CAP) as it governs new fundraising and financing activities.
2025-11-04 English
Other.pdf
Capital/Financing Update Classification · 1% confidence The document is a loan agreement detailing terms of multiple loans (Xemxija, ITF, EGrima) to CardioComm Solutions, including loan amounts, interest, repayment, security, and issuance of bonus shares and warrants. It is not an earnings release or regulatory form but rather a financing arrangement. Under the taxonomy, this constitutes a Capital/Financing Update (CAP).
2025-11-04 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the termination of a royalty agreement and entry into a $512,000 insider loan facility, providing detailed terms of the loan agreement, use of proceeds, and related party disclosures. This falls squarely under fundraising and financing activities (insider loan facility) rather than an earnings release, management change, or annual/interim report. Consequently, it is classified as a Capital/Financing Update.
2025-11-04 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press‐style voluntary disclosure announcing the CEO’s purchase of a company loan (insider debt consolidation). It is not an Annual Report, audit, earnings or regulatory form filing, nor is it a share issuance or dividend notice. There is no formal report attached—this is simply an announcement of an insider transaction that does not involve equity. It therefore falls into the miscellaneous regulatory announcement fallback category: RNS.
2025-09-26 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is Form 45-106F1 (Report of Exempt Distribution), a Canadian securities regulatory report detailing the distribution of securities under NI 45-106. It is neither an earnings release nor a management or annual report but a mandatory regulatory filing for an exempt distribution. It does not match more specific categories like M&A, capital raise presentation, or director dealings, so it falls under the general Regulatory Filings (RNS) category.
2025-08-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.